/company-about-us.htm

OUR FOCUS: Helping children live better lives

DELIVERING TRUSTED RESULTS

Courtagen is committed to helping physicians, families, and children suffering with neurological disorders. Test results provide your doctor with genetic information to help diagnose disease and guide treatment decisions. Genetic testing can lead to positive changes or, in some cases, major improvements in a child’s quality of life.

Courtagen offers clinical genetic tests for:

Developmental Delay, Intellectual Disability, Autism Spectrum Disorders
Epilepsy and Seizure Disorders
Mitochondrial Disorders


AN EASY TEST TO TAKE

Our DNA test is easy, painless, and less stressful for you and your child. Unlike other companies, Courtagen’s tests are validated on saliva samples. Follow the simple instructions in our saliva kit, mail us your sample (using the postage-paid box provided), and we will send your customized report directly to your doctor. Blood and tissue samples are also accepted by our laboratory.

PAYMENT OPTIONS

We offer the Courtagen Care Financial Assistance Plan for patients based on demonstrated financial need. A qualified applicant may be asked to contribute between $0 and a maximum cost sharing of $200 depending on determination of financial need.

FAST RESULTS

You shouldn’t have to wait. Courtagen test results come back fast, helping you get closer to answers in weeks—not months.

CUT THROUGH THE COMPLEXITY

Pediatric neurological disorders such as mitochondrial disease, epilepsy, and autism spectrum disorder are complex and often difficult to understand, diagnose, and manage effectively. Courtagen’s comprehensive approach to genetic testing can help shed light on new information and potential treatment options for your doctor to explore.

LEADING THE WAY IN NEXT GENERATION SEQUENCING

We don’t just collect samples and generate results. As leaders in Next Generation Sequencing, we’ve implemented the most advanced laboratory methods, resulting in the highest quality data. Our highly experienced bioinformatics team and analysis pipeline converts sequence information into useable test results for your physician.

EXPERT INTERPRETATION

Before being sent to your doctor, test results are examined and interpreted by our team of industry- leading geneticists and clinical experts, including our Medical Director, Dr. Richard Boles. With over 25 years of experience in pediatric neurology, our team’s invaluable insights transform information into answers.

WE CAN DO THIS—TOGETHER

Get started today by asking your doctor what Courtagen can do for you. If you have questions or want
to learn more, call our patient advocacy group at 1.877.395.7608 or email us at genomics@courtagen.com.

Webinar: Gene Panels: A
Powerful Addition to the 
Clinician's Toolbox
feat. Christine Stanley, PhD, FACMG

Recorded on Sept. 9th, 2016

Click Here to View Online

Courtagen Blog

Latest News & Updates 

Whole Exome Sequencing

Click here for more information

Courtagen Gives Back


COURTAGEN NEWS

Courtagen Life Sciences Collaborates with Astellas Pharma For Mitochondrial Disorder Drug Development


U.S. Patent Granted for Courtagen’s Novel DREAM™ PCR Decontamination Technology


Courtagen Life Sciences Adds Pediatric Neurologist, Ngoc Minh Le, M.D., to the Company's Clinical Team


Medicinal Genomics Revolutionizes Cannabis Industry with Introduction of Strain ID & Certification Service

CannMed 2016 Conference to be Live Streamed Including the Keynote Speech by Noted Israeli Marijuana Research Pioneer Dr. Raphael Mechoulam


Courtagen and Medicinal Genomics Announce Expanded Speaker List for CannMed 2016 – 1st Annual Cannabis Medical Research Conference Being Held in Cambridge, MA in April


CannMed2016 Announces That Kyle Turley, Former NFL Pro Bowler and Leading Cannabis Advocate, Will Speak at 1st Annual Cannabis Medical Research Conference Being Held in Cambridge, MA in April


Courtagen Life Sciences Receives New York State Clinical Laboratory Approval


Courtagen and Medicinal Genomics Announce CannMed 2016, the Personalized Cannabinoid Medicine Conference, April 10-11, 2016


Courtagen Closes Expanding Financing Totaling ~$20 million


Courtagen Launches the rxSEEK™ Epilepsy Clinical Genetic Test


Courtagen Appoints Helio Pedro, MD to the Company's Clinical And Strategic Advisory Board